Hotline:
+ 49 (0) 2204 2918806

Market studies for category X

Items 1 to 10 of 543 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 55
  1. Net price*
    Year
  2. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Affichem - Product Pipeline Review - 2013

    Global Markets Direct
    19 pages
    Global Market Direct’s pharmaceuticals report, “Affichem - Product Pipeline Review - 2013” provides data on the Affichem’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using da
    Englisch | Zukunftsanalyse | SKU: 354771
  3. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Autism - Pipeline Review, H2 2013

    Global Markets Direct
    91 pages
    Global Markets Direct’s, 'Autism - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Autism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the
    Englisch | Zukunftsanalyse | SKU: 355123
  4. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Angina (Angina Pectoris) - Pipeline Review, H2 2013

    Global Markets Direct
    73 pages
    Global Markets Direct’s, 'Angina (Angina Pectoris) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Angina (Angina Pectoris), complete with latest updates, and special features on late-stage and discontinued projects. It also
    Englisch | Zukunftsanalyse | SKU: 354835
  5. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Premature Ejaculation - Pipeline Review, H2 2013

    Global Markets Direct
    61 pages
    Global Markets Direct’s, 'Premature Ejaculation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Premature Ejaculation, complete with latest updates, and special features on late-stage and discontinued projects. It also revie
    Englisch | Zukunftsanalyse | SKU: 355187
  6. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Chronic Heart Failure - Pipeline Review, H2 2013

    Global Markets Direct
    93 pages
    Global Markets Direct’s, 'Chronic Heart Failure - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chronic Heart Failure, complete with latest updates, and special features on late-stage and discontinued projects. It also revie
    Englisch | Zukunftsanalyse | SKU: 354899
  7. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Wockhardt Limited - Product Pipeline Review - 2013

    Global Markets Direct
    34 pages
    Global Markets Direct’s pharmaceuticals report, “Wockhardt Limited - Product Pipeline Review - 2013” provides data on the Wockhardt Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This repor
    Englisch | Zukunftsanalyse | SKU: 354963
  8. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Gene Signal International SA - Product Pipeline Review - 2013

    Global Markets Direct
    28 pages
    Global Markets Direct’s pharmaceuticals report, “Gene Signal International SA - Product Pipeline Review - 2013” provides data on the Gene Signal International SA’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorman
    Englisch | Zukunftsanalyse | SKU: 355027
  9. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    arGEN-X BV - Product Pipeline Review - 2013

    Global Markets Direct
    24 pages
    Global Market Direct’s pharmaceuticals report, “arGEN-X BV - Product Pipeline Review - 2013” provides data on the arGEN-X BV’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built usin
    Englisch | Zukunftsanalyse | SKU: 354738
  10. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Lycera Corp. - Product Pipeline Review - 2013

    Global Markets Direct
    22 pages
    Global Markets Direct’s pharmaceuticals report, “Lycera Corp. - Product Pipeline Review - 2013” provides data on the Lycera Corp.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built
    Englisch | Zukunftsanalyse | SKU: 355091
  11. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Myocardial Infarction - Pipeline Review, H2 2013

    Global Markets Direct
    258 pages
    Global Markets Direct’s, 'Myocardial Infarction - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Myocardial Infarction, complete with latest updates, and special features on late-stage and discontinued projects. It also revie
    Englisch | Zukunftsanalyse | SKU: 354803

Items 1 to 10 of 543 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 55